The DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.
Cancer cachexia is regulated by selective targeting of skeletal muscle gene products
Open accessAbstract
Cachexia is a syndrome characterized by wasting of skeletal muscle and contributes to nearly one-third of all cancer deaths. Cytokines and tumor factors mediate wasting by suppressing muscle gene products, but exactly which products are targeted by these cachectic factors is not well understood. Because of their functional relevance to muscle architecture, such targets are presumed to represent myofibrillar proteins, but whether these proteins are regulated in a general or a selective manner is also unclear. Here we demonstrate, using in vitro and in vivo models of muscle wasting, that cachectic factors are remarkably selective in targeting myosin heavy chain. In myotubes and mouse muscles, TNF-alpha plus IFN-gamma strongly reduced myosin expression through an RNA-dependent mechanism. Likewise, colon-26 tumors in mice caused the selective reduction of this myofibrillar protein, and this reduction correlated with wasting. Under these conditions, however, loss of myosin was associated with the ubiquitin-dependent proteasome pathway, which suggests that mechanisms used to regulate the expression of muscle proteins may be cachectic factor specific. These results shed new light on cancer cachexia by revealing that wasting does not result from a general downregulation of muscle proteins but rather is highly selective as to which proteins are targeted during the wasting state.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sandri, M., Sandri, C., Gilbert, A., Skurk, C., Calabria, E., Picard, A., Walsh, K., Schiaffino, S., Lecker, S. H., & Goldberg, A. L. (2004) · Cell · doi:10.1016/s0092-8674(04)00400-3 · Cited by 3,012
Stitt, T. N., Drujan, D., Clarke, B. A., Panaro, F., Timofeyva, Y., Kline, W. O., Gonzalez, M., Yancopoulos, G. D., & Glass, D. J. (2004) · Molecular Cell · doi:10.1016/s1097-2765(04)00211-4 · Cited by 1,964
Multiple types of skeletal muscle atrophy involve a common program of changes in gene expression
Lecker, S. H., Jagoe, R. T., Gilbert, A., Gomes, M., Baracos, V., Bailey, J., Price, S. R., Mitch, W. E., & Goldberg, A. L. (2004) · The FASEB Journal · doi:10.1096/fj.03-0610com · Cited by 1,539
NF-κB Controls Cell Growth and Differentiation through Transcriptional Regulation of Cyclin D1
Guttridge, D. C., Albanese, C., Reuther, J. Y., Pestell, R. G., & Baldwin, A. S. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.8.5785 · Cited by 1,312
Self-citationMechanisms of Muscle Wasting — The Role of the Ubiquitin–Proteasome Pathway
Mitch, W. E., & Goldberg, A. L. (1996) · New England Journal of Medicine · doi:10.1056/nejm199612193352507 · Cited by 1,166
Tisdale, M. J. (2002) · Nature Reviews Cancer · doi:10.1038/nrc927 · Cited by 982
NF-κB-Induced Loss of MyoD Messenger RNA: Possible Role in Muscle Decay and Cachexia
Guttridge, D. C., Mayo, M. W., Madrid, L. V., Wang, C.-Y., & Baldwin Jr., A. S. (2000) · Science · doi:10.1126/science.289.5488.2363 · Cited by 924
Self-citationTumor Necrosis Factor, Other Cytokines and Disease
Tracey, K. J., & Cerami, A. (1993) · Annual Review of Cell Biology · doi:10.1146/annurev.cb.09.110193.001533 · Cited by 783
The MyoD DNA binding domain contains a recognition code for muscle-specific gene activation
Davis, R. L., Cheng, P.-F., Lassar, A. B., & Weintraub, H. (1990) · Cell · doi:10.1016/0092-8674(90)90088-v · Cited by 765
Lecker, S. H., Solomon, V., Mitch, W. E., & Goldberg, A. L. (1999) · The Journal of Nutrition · doi:10.1093/jn/129.1.227s · Cited by 732
Cachectin/tumor necrosis factor induces cachexia, anemia, and inflammation.
Tracey, K. J., Wei, H., Manogue, K. R., Fong, Y., Hesse, D. G., Nguyen, H. T., Kuo, G. C., Beutler, B., Cotran, R. S., & Cerami, A. (1988) · The Journal of experimental medicine · doi:10.1084/jem.167.3.1211 · Cited by 730
Striated Muscle Cytoarchitecture: An Intricate Web of Form and Function
Clark, K. A., McElhinny, A. S., Beckerle, M. C., & Gregorio, C. C. (2002) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.18.012502.105840 · Cited by 674
Evidence for the involvement of interleukin 6 in experimental cancer cachexia.
Strassmann, G., Fong, M., Kenney, J. S., & Jacob, C. O. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115767 · Cited by 658
Tumors secreting human TNF/cachectin induce cachexia in mice
Oliff, A., Defeo-Jones, D., Boyer, M., Martinez, D., Kiefer, D., Vuocolo, G., Wolfe, A., & Socher, S. H. (1987) · Cell · doi:10.1016/0092-8674(87)90028-6 · Cited by 640
Dantuma, N. P., Lindsten, K., Glas, R., Jellne, M., & Masucci, M. G. (2000) · Nature Biotechnology · doi:10.1038/75406 · Cited by 553
Ruan, H., Hacohen, N., Golub, T. R., Van Parijs, L., & Lodish, H. F. (2002) · Diabetes · doi:10.2337/diabetes.51.5.1319 · Cited by 529
Li, Y.-P., Schwartz, R. J., Waddell, I. D., Holloway, B. R., & Reid, M. B. (1998) · The FASEB Journal · doi:10.1096/fasebj.12.10.871 · Cited by 499
Tisdale, M. J. (1997) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/89.23.1763 · Cited by 487
NF-κB mediates the protein loss induced by TNF-α in differentiated skeletal muscle myotubes
Li, Y.-P., & Reid, M. B. (2000) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.2000.279.4.r1165 · Cited by 441
Characterization of a cancer cachectic factor
Todorov, P., Cariuk, P., McDevitt, T., Coles, B., Fearon, K., & Tisdale, M. (1996) · Nature · doi:10.1038/379739a0 · Cited by 437
Solomon, V., & Goldberg, A. L. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.43.26690 · Cited by 429
EVIDENCE FOR TUMOUR NECROSIS FACTOR/CACHECTIN PRODUCTION IN CANCER
Balkwill, F., Burke, F., Talbot, D., Tavernier, J., Osborne, R., Naylor, S., Durbin, H., & Fiers, W. (1987) · The Lancet · doi:10.1016/s0140-6736(87)91850-2 · Cited by 418
Inflammatory cytokines inhibit myogenic differentiation through activation of nuclear factor‐κΒ
LANGEN, R. C. J., SCHOLS, A. M. W. J., KELDERS, M. C. J. M., WOUTERS, E. F. M., & JANSSEN-HEININGER, Y. M. W. (2001) · The FASEB Journal · doi:10.1096/fj.00-0463 · Cited by 415
Medina, R., Wing, S. S., & Goldberg, A. L. (1995) · Biochemical Journal · doi:10.1042/bj3070631 · Cited by 293
Costelli, P., Carbó, N., Tessitore, L., Bagby, G. J., Lopez-Soriano, F. J., Argilés, J. M., & Baccino, F. M. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116897 · Cited by 289
Cachectin/TNF or IL-1 alpha induces cachexia with redistribution of body proteins
Fong, Y., Moldawer, L. L., Marano, M., Wei, H., Barber, A., Manogue, K., Tracey, K. J., Kuo, G., Fischman, D. A., Cerami, A., et al. (1989) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1989.256.3.r659 · Cited by 266
Baracos, V. E., DeVivo, C., Hoyle, D. H., & Goldberg, A. L. (1995) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1995.268.5.e996 · Cited by 263
Gélin, J., Moldawer, L. L., Lönnroth, C., Sherry, B. A., Chizzonite, R., & Lundholm, K. (1991) · PubMed · Cited by 251
TNF‐α increases ubiquitin‐conjugating activity in skeletal muscle by up‐regulating UbcH2/E2 20k
LI, Y.-P., LECKER, S. H., CHEN, Y., WADDELL, I. D., GOLDBERG, A. L., & REID, M. B. (2003) · The FASEB Journal · doi:10.1096/fj.02-0759com · Cited by 243
The role of cytokines in cancer cachexia
Argilés, J. M. A., & López-Soriano, F. J. (1999) · Medicinal Research Reviews · doi:10.1002/(sici)1098-1128(199905)19:3<223::aid-med3>3.0.co;2-n · Cited by 234
Ladner, K. J., Caligiuri, M. A., & Guttridge, D. C. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m207129200 · Cited by 233
Self-citationThrough thick and thin: Wasting, obesity, and TNFα
Spiegelman, B. M., & Hotamisligil, G. S. (1993) · Cell · doi:10.1016/0092-8674(93)90243-j · Cited by 217
Increased ATP-ubiquitin-dependent proteolysis in skeletal muscles of tumor-bearing rats.
Temparis, S., Asensi, M., Taillandier, D., AUROUSSEAU, E., Larbaud, D., Obled, A., Béchet, D., Ferrara, M., Estrela, J. M., & Attaix, D. (1994) · PubMed · Cited by 214
A Predictive Scale for Evaluating Cyclin-dependent Kinase Substrates
Holmes, J. K., & Solomon, M. J. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.41.25240 · Cited by 201
Interleukin 1 and tumor necrosis factor do not regulate protein balance in skeletal muscle
Moldawer, L. L., Svaninger, G., Gelin, J., & Lundholm, K. G. (1987) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1987.253.6.c766 · Cited by 196
Sepsis stimulates release of myofilaments in skeletal muscle by a calcium‐dependent mechanism
Williams, A. B., Decourten‐Myers, G. M., Fischer, J. E., Luo, G., Sun, X., & Hasselgren, P. (1999) · The FASEB Journal · doi:10.1096/fasebj.13.11.1435 · Cited by 187
Interleukin-15 antagonizes muscle protein waste in tumour-bearing rats
Carbó, N., López-Soriano, J., Costelli, P., Busquets, S., Alvarez, B., Baccino, F. M., Quinn, L. S., López-Soriano, F. J., & Argilés, J. M. (2000) · British Journal of Cancer · doi:10.1054/bjoc.2000.1299 · Cited by 181
An E-box within the MHC IIB gene is bound by MyoD and is required for gene expression in fast muscle
Wheeler, M. T., Snyder, E. C., Patterson, M. N., & Swoap, S. J. (1999) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1999.276.5.c1069 · Cited by 172
Self-citationPhase II Study of Recombinant Human Interferon Gamma for Treatment of Cutaneous T-Cell Lymphoma
Kaplan, E. H., Rosen, S. T., Norris, D. B., Roenigk, H. H., Saks, S. R., & Bunn, P. A. (1990) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/82.3.208 · Cited by 168
Severe cachexia in mice inoculated with interferon‐γ‐producing tumor cells
Matthys, P., Dukmans, R., Proost, P., Damme, J. V., Heremans, H., Sobis, H., & Billiau, A. (1991) · International Journal of Cancer · doi:10.1002/ijc.2910490115 · Cited by 157
Ouaaz, F., Li, M. O., & Beg, A. A. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.6.999 · Cited by 144
Evans, W. K., Makuch, R., Clamon, G. H., Feld, R. D., Weiner, R. S., Moran, E. M., Blum, R., Shepherd, F. A., Jeejeebhoy, K. N., & DeWys, W. D. (1986) · Lung Cancer · doi:10.1016/s0169-5002(86)80124-6 · Cited by 135
Serum levels of tumor necrosis factor-alpha and nutritional status in pancreatic cancer patients.
Karayiannakis, A. J., Syrigos, K. N., Polychronidis, A., Pitiakoudis, M. S., Bounovas, A., & Simopoulos, K. (2001) · PubMed · Cited by 133
Cancer cachexia: the molecular mechanisms
Argilés, J. M. A., Moore‐Carrasco, R., Fuster, G., Busquets, S., & López-Soriano, F. J. (2003) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(02)00251-0 · Cited by 132
Strassmann, G., Fong, M., Freter, C. E., Windsor, S., D'Alessandro, F., & Nordan, R. P. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116816 · Cited by 131
Association between tumor necrosis factor in serum and cachexia in patients with prostate cancer.
Nakashima, J., Tachibana, M., Ueno, M., Miyajima, A., Baba, S., & Murai, M. (1998) · PubMed · Cited by 128
Valls, M. R. A., Santolaria, F., Batista, N., Vega, M. J. D. L., González‐Reimers, E., Milena, A., Llanos, M., & Gómez-Sirvent, J. L. (2002) · Cytokine · doi:10.1006/cyto.2002.1051 · Cited by 121
Role of TNF receptor 1 in protein turnover during cancer cachexia using gene knockout mice
Llovera, M., Garcia‐Martínez, C., López‐Soriano, J., Carbó, N., Agell, N., López-Soriano, F. J., & Argilés, J. M. A. (1998) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(98)00105-1 · Cited by 120
CACHECTIN/TUMOUR-NECROSIS-FACTOR PRODUCTION BY CANCER PATIENTS
Aderka, D., Fisher, S. G., Levo, Y., Holtmann, H., Hahn, T., & Wallach, D. (1985) · The Lancet · doi:10.1016/s0140-6736(85)92713-8 · Cited by 118
Altered expression of skeletal muscle myosin isoforms in cancer cachexia
Diffee, G. M., Kalfas, K., Al‐Majid, S., & McCarthy, D. O. (2002) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00154.2002 · Cited by 114
Mechanisms of experimental cancer cachexia. Local involvement of IL-1 in colon-26 tumor
Strassmann, G., Masui, Y., Chizzonite, R., & Fong, M. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.150.6.2341 · Cited by 112
IL-6-Like Cytokines and Cancer Cachexia: Consequences of Chronic Inflammation
Barton, B. E. (2001) · Immunologic Research · doi:10.1385/ir:23:1:41 · Cited by 110
Growth and Muscle Defects in Mice Lacking Adult Myosin Heavy Chain Genes
Acakpo‐Satchivi, L., Edelmann, W., Sartorius, C. A., Lu, B. D., Wahr, P. A., Watkins, S. C., Metzger, J. M., Leinwand, L. A., & Kucherlapati, R. (1997) · The Journal of Cell Biology · doi:10.1083/jcb.139.5.1219 · Cited by 91
Yasumoto, K., Mukaida, N., Harada, A., Kuno, K., Akiyama, M., Nakashima, E., Fujioka, N., Mai, M., Kasahara, T., & Fujimoto-Ouchi, K. (1995) · PubMed · Cited by 88
Layne, M. D., & Farmer, S. R. (1999) · Experimental Cell Research · doi:10.1006/excr.1999.4465 · Cited by 73
Protein synthesis measured in vivo in muscle and liver of cachectic tumor-bearing mice.
Emery, P., Lovell, L., & Rennie, M. J. (1984) · Cancer Research · doi:10.1016/0278-2391(85)90177-6 · Cited by 66
In vivo analysis of the myosin heavy chain IIB promoter region
Swoap, S. J. (1998) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1998.274.3.c681 · Cited by 66
Self-citationThe fine structure of type II muscle fiber atrophy
Mendell, J. R., & Engel, W. K. (1971) · Neurology · doi:10.1212/wnl.21.4.358 · Cited by 64
A phase I study of recombinant interleukin 2 plus recombinant beta-interferon.
Krigel, R. L., Padavic‐Shaller, K., Rudolph, A. R., Litwin, S., Konrad, M., Bradley, E. C., & Comis, R. L. (1988) · PubMed · Cited by 54
The syndrome of anorexia-cachexia
Body, J. J. (1999) · Current Opinion in Oncology · doi:10.1097/00001622-199907000-00004 · Cited by 49
The divergent effects of tumour necrosis factor-alpha on skeletal muscle: implications in wasting.
Argilés, J. M. A., Alvarez, B., Carbó, N., Busquets, S., van Royen, M. E., & López-Soriano, F. J. (2000) · PubMed · Cited by 32
Probing the proteasome pathway
Goldberg, A. L. (2000) · Nature Biotechnology · doi:10.1038/75349 · Cited by 22
Cited by
Evans, W. J., Morley, J. E., Argilés, J., Bales, C., Baracos, V., Guttridge, D., Jatoi, A., Kalantar-Zadeh, K., Lochs, H., Mantovani, G., et al. (2008) · Clinical Nutrition · doi:10.1016/j.clnu.2008.06.013 · Cited by 2,450
Self-citationBaracos, V. E., Martin, L., Korc, M., Guttridge, D. C., & Fearon, K. C. H. (2018) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2017.105 · Cited by 1,738
Self-citationTumors as Organs: Complex Tissues that Interface with the Entire Organism
Egeblad, M., Nakasone, E. S., & Werb, Z. (2010) · Developmental Cell · doi:10.1016/j.devcel.2010.05.012 · Cited by 1,234
Tisdale, M. J. (2009) · Physiological Reviews · doi:10.1152/physrev.00016.2008 · Cited by 1,192
Sandri, M., Lin, J., Handschin, C., Yang, W., Arany, Z. P., Lecker, S. H., Goldberg, A. L., & Spiegelman, B. M. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0607795103 · Cited by 974
Metadata
- Authors
- Acharyya, S., Ladner, K. J., Nelsen, L. L., Damrauer, J., Reiser, P. J., Swoap, S., & Guttridge, D. C.
- Venue
- Journal of Clinical Investigation
- Published
- 2004-08-01
- Volume
- 114
- Issue
- 3
- Pages
- 370-378
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2122248675
- Cited by
- 542
- References
- 62
- FWCI
- 12.36
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.